Cardiac Science Inc.
The Irvine medical products developer reported a first-quarter net loss of $2.7 million, or 22 cents a share, compared with a net loss of $1.2 million, or 16 cents a share, for the first quarter of 1999. Revenue totaled $624,642. The company reported no revenue for the same period in 1999.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
